Table 3 Results of the GuacaMol goal-directed optimization task
Task | FRATTVAE +MSO | MoLeR* +MSO | Best of Dataset | GraphGA‡ | CReM‡ |
|---|---|---|---|---|---|
Celecoxib rediscovery | 0.835 | 0.868 | 0.505 | 1.000 | 1.000 |
Troglitazone rediscovery | 0.817 | 0.544 | 0.419 | 1.000 | 1.000 |
Thiothixene rediscovery | 0.589 | 0.649 | 0.456 | 1.000 | 1.000 |
Aripiprazole similarity | 0.976 | 0.894 | 0.595 | 1.000 | 1.000 |
Albuterol similarity | 0.946 | 0.920 | 0.719 | 1.000 | 1.000 |
Mestranol similarity | 0.804 | 0.741 | 0.629 | 1.000 | 1.000 |
C11H24 | 0.967 | 0.969 | 0.684 | 0.971 | 0.966 |
C9H10N2O2PF2Cl | 0.841 | 0.881 | 0.747 | 0.982 | 0.940 |
Median molecules 1 | 0.358 | 0.353 | 0.334 | 0.406 | 0.371 |
Median molecules 2 | 0.342 | 0.317 | 0.351 | 0.432 | 0.434 |
Osimertinib MPO | 0.899 | 0.875 | 0.839 | 0.953 | 0.995 |
Fexofenadine MPO | 0.891 | 0.890 | 0.817 | 0.998 | 1.000 |
Ranolazine MPO | 0.855 | 0.866 | 0.792 | 0.920 | 0.969 |
Perindopril MPO | 0.695 | 0.566 | 0.575 | 0.792 | 0.815 |
Amlodipine MPO | 0.791 | 0.663 | 0.696 | 0.894 | 0.902 |
Sitagliptin MPO | 0.613 | 0.736 | 0.509 | 0.891 | 0.763 |
Zaleplon MPO | 0.584 | 0.612 | 0.547 | 0.754 | 0.770 |
Valsartan MPO | 0.823 | 0.747 | 0.259 | 0.990 | 0.994 |
Deco Hop | 0.935 | 0.941 | 0.933 | 1.000 | 1.000 |
Scaffold Hop | 0.880 | 0.817 | 0.738 | 1.000 | 1.000 |
Average | 0.772 | 0.742 | 0.607 | 0.899 | 0.896 |
Quality | 0.782 | 0.652 | 0.786 | 0.398 | 0.524 |
SA Score | 3.126 | 3.291 | 2.989 | 3.975 | 3.506 |